- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT01347541
Piloting Acute Care to Primary Care Linkage of Safety Net Patients (TSOS III)
Descripción general del estudio
Estado
Condiciones
Descripción detallada
The investigators plan to implement a pilot linkage program in which trauma center based care facilitators will use a population-based recruitment strategy to facilitate outpatient follow-up for acutely injured trauma center inpatients and emergency department patients. All patients recruited into the trial will be low income patients with one or more of the following characteristics: being uninsured, low income older adults, low income mothers, and other high risk individuals who lack health insurance. Patients will be linked for care to one of the community health centers participating in Washington State.
In phase I, patients will be recruited from the trauma center inpatient trauma surgery service and emergency departments. In phase one, no randomization will occur; patients will be linked to one of the community health centers. Patients who consent to the protocol will be assessed in the surgical inpatient units or emergency department. After the baseline assessment, all patients will be immediately assigned a bachelor's, MSW, or RN level care manager. The care managers will elicit and address posttraumatic concerns, and attempt linkage of patients to community programs. Care managers may also deliver motivational interviewing and cognitive behavioral therapy interventions. Patient may also be linked to psychopharmacologic interventions targeting PTSD. Follow-up assessments will occur in the weeks and months after the injury and will assess patterns of health service utilization and symptomatic outcomes. Phase I will establish the feasibility of recruitment and follow-up, acceptability of care management for patients, as well as the pragmatics of linkage to community programs.
Piloting in phase II will depend on the results of phase I; the phase II pilot will build and extend upon phase I. In phase II, patients will be randomized to either intervention or control conditions. Patients randomized to the intervention condition will be met by a care manager who may address patients' initial needs and concerns. Care managers may also deliver Motivational Interviewing and Cognitive Behavioral Therapy interventions. Patients may also be linked to psychopharmacologic interventions targeting PTSD. The care manager will attempt to link patients to participating community health centers. Linkages may occur by the telephone, or through web-based clinical registry tools that are under development by the intervention team. Some linkages may occur in person. To determine if intervention patients are successfully linked more frequently than controls, all patients will be followed from the time of designation at hospital admission to outpatient primary care appointments. Follow-up outcome assessments will occur in the weeks and months post-injury and will includes assessments of patterns of health service utilization, function, and symptomatic outcomes.
Tipo de estudio
Inscripción (Actual)
Fase
- Fase 1
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Washington
-
Seattle, Washington, Estados Unidos, 98104
- Harborview Medical Center
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- English-speaking
- Admitted to Harborview Medical Center with injuries sufficiently severe enough to require inpatient admission
- Experienced a traumatic injury
- Exhibits symptoms of PTSD while in the hospital ward
- Low-income
Exclusion Criteria:
- History of head, spinal, or other injury that may prevent participation in the ward interview
- Requires immediate intervention due to conditions such as self-inflicted injury, active psychosis, or active mania
- Currently incarcerated
- Likely to face criminal charges
- Lives outside of the state of Washington
- Not low-income
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación factorial
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Stepped care
Combination of behavioral therapy and drug therapy
|
Behavioral therapy includes standard cognitive behavioral therapy, with an emphasis on behavioral activation.
Treatment is administered on the basis of the participants' individual needs and may continue for up to 12 months.
Otros nombres:
Motivational interviewing is designed to address alcohol and drug use.
Otros nombres:
Participants assigned to receive the combination therapy may receive one or more of the following medications based on their individual needs: fluoxetine, sertraline, paroxetine, buspirone, propranolol, trazodone, and any of the benzodiazepines.
Participants may begin receiving medication immediately or anytime within the 12 months post-injury.
Form, dosage, frequency, and duration depend on patient need, but all are prescribed in accordance with standards of care.
|
|
Comparador activo: Standard care provided to injured trauma survivors
|
Standard care control includes the usual treatment for injured trauma survivors
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change From Baseline Alcohol Use Disorders Identification at 1 Month
Periodo de tiempo: Baseline, Up to 12 months after injury
|
The investigators will use the Alcohol Use Disorders Identification Test (AUDIT) as a continuous measure.
The 10-item scale score ranges from 0-40, with higher values indicating a worse outcome.
|
Baseline, Up to 12 months after injury
|
|
Change From Baseline PTSD Checklist Civilian (PCL-C) at 1 Month
Periodo de tiempo: Baseline, Up to 12 months after injury
|
The investigators will use the PTSD Checklist - Civilian (PCL-C).
The scoring of the scale ranges from a minimum of 17 to a maximum of 85, with higher scores indicating a worse outcome.
The measure can also provide a rating of symptoms consistent with a diagnosis of PTSD.
|
Baseline, Up to 12 months after injury
|
|
Change in Functional Status at 1 Month
Periodo de tiempo: Baseline, Up to 12 months after injury
|
The investigators will use the Medical Outcomes Study Short Form healthy survey (MOS SF-12/36) physical components summary to assess physical function.
The minimum and maximum scores are 0-100 with higher scores representing a better outcome.
|
Baseline, Up to 12 months after injury
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Increased Satisfaction With Global Care
Periodo de tiempo: Up to 12 months after injury
|
Assessed using the Posttraumatic Growth Inventory (PTGI) and Satisfaction with Care (NSCOT)
|
Up to 12 months after injury
|
|
Injury Relapse
Periodo de tiempo: Up to 5 years after injury
|
Assessed using Healthcare Utilization Questions (NSCOT)
|
Up to 5 years after injury
|
|
Work, Disability, and Legal Outcomes
Periodo de tiempo: Up to 12 months after injury
|
Assessed using Work, Disability and Legal (NSCOT) and Sheehan Disability Scale (SDS)
|
Up to 12 months after injury
|
Colaboradores e Investigadores
Patrocinador
Publicaciones y enlaces útiles
Publicaciones Generales
- Zatzick D, Roy-Byrne P, Russo J, Rivara F, Droesch R, Wagner A, Dunn C, Jurkovich G, Uehara E, Katon W. A randomized effectiveness trial of stepped collaborative care for acutely injured trauma survivors. Arch Gen Psychiatry. 2004 May;61(5):498-506. doi: 10.1001/archpsyc.61.5.498.
- Zatzick DF, Roy-Byrne P, Russo JE, Rivara FP, Koike A, Jurkovich GJ, Katon W. Collaborative interventions for physically injured trauma survivors: a pilot randomized effectiveness trial. Gen Hosp Psychiatry. 2001 May-Jun;23(3):114-23. doi: 10.1016/s0163-8343(01)00140-2.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 40069
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .